Cargando…
Alternative management of central serous chorioretinopathy using intravitreal metoprolol
BACKGROUND: Beta-blockers may counteract the effect of catecholamines on central serous chorioretinopathy (CSC) pathology and accelerate the improvement of neurosensory retinal detachment. Oral propranolol has been associated with decreased duration of CSC in some studies. We describe two patients w...
Autores principales: | Gonçalves, Annelise Nicotti, Scott, Ingrid U., Jorge, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310426/ https://www.ncbi.nlm.nih.gov/pubmed/35879809 http://dx.doi.org/10.1186/s40942-022-00400-5 |
Ejemplares similares
-
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
por: Cuevas, Pedro, et al.
Publicado: (2012) -
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018) -
Alternating central serous chorioretinopathy in two consecutive pregnancies
por: Al-Mujaini, Abdullah, et al.
Publicado: (2014) -
Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant
por: Noh, Gwang Myeong, et al.
Publicado: (2019)